We talked about popular long holdings of hedge funds in an earlier post, but a look at short positions from Goldman Sachs hedge fund trend monitor also reveals interesting insights.
Short interest high in biotech/pharma sector
Short interest in Myriad Genetics, Inc. (NASDAQ:MYGN) is still riding high as an unprecedented number, 55%, of outstanding shares are held in short bets. Negative interest in the biotech and pharmaceutical companies is clearly visible in the list, EXACT Sciences Corporation (NASDAQ:EXAS), Questcor Pharmaceuticals Inc (NASDAQ:QCOR), Horizon Pharma Inc (NASDAQ:HZNP) and Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) all have high short interest.
The metals and mining sector...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full ArticleAlready a member? Log in here
